• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Exploring the demand for a voluntary Medicare prescription drug benefit.探索对自愿性医疗保险处方药福利的需求。
AAPS PharmSci. 2003;5(2):E19. doi: 10.1208/ps050219.
2
PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.PDP 还是 MA-PD?CMS 第 25 区的医疗保险部分 D 注册决策。
Res Social Adm Pharm. 2010 Jun;6(2):130-42. doi: 10.1016/j.sapharm.2010.04.002.
3
Medicare program; Medicare prescription drug benefit. Final rule.医疗保险计划;医疗保险处方药福利。最终规则。
Fed Regist. 2005 Jan 28;70(18):4193-585.
4
Impact of cost sharing on prescription drugs used by Medicare beneficiaries.医疗保险受益人的处方药费用分担的影响。
Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.
5
Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage.2006年医疗保险D部分参保情况报告:特定计划的市场份额与覆盖范围分析
Health Aff (Millwood). 2007 Jan-Feb;26(1):w1-12. doi: 10.1377/hlthaff.26.1.w1. Epub 2006 Nov 21.
6
Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.陷入“甜甜圈洞”:医疗保险D部分计划下终末期肾病受益人的药品支出
J Am Soc Nephrol. 2006 Sep;17(9):2546-53. doi: 10.1681/ASN.2005121385. Epub 2006 Jul 19.
7
Adverse selection in the Medicare prescription drug program.医疗保险处方药计划中的逆向选择。
Health Aff (Millwood). 2009 Nov-Dec;28(6):1826-37. doi: 10.1377/hlthaff.28.6.1826.
8
Will the Medicare prescription drug benefit eliminate cost barriers for older adults with diabetes mellitus?医疗保险处方药福利能否消除老年糖尿病患者的费用障碍?
J Am Geriatr Soc. 2006 Apr;54(4):606-12. doi: 10.1111/j.1532-5415.2006.00663.x.
9
The new Medicare drug benefit: much ado about little?新的医疗保险药品福利:小题大做?
LDI Issue Brief. 2004 Jan-Feb;9(4):1-6.
10
Factors affecting demand among older adults for medication therapy management services.影响老年人对药物治疗管理服务需求的因素。
Res Social Adm Pharm. 2008 Dec;4(4):309-19. doi: 10.1016/j.sapharm.2007.11.003. Epub 2008 Aug 8.

引用本文的文献

1
Main Determinants of Supplementary Health Insurance Demand: (Case of Iran).补充健康保险需求的主要决定因素:(伊朗案例)
Glob J Health Sci. 2015 Apr 23;7(6):285-94. doi: 10.5539/gjhs.v7n6p285.
2
Views of health system experts on macro factors of induced demand.卫生系统专家对诱导需求宏观因素的看法。
Int J Prev Med. 2014 Oct;5(10):1286-98.

本文引用的文献

1
Demand for a Medicare prescription drug benefit: exploring consumer preferences under a managed competition framework.对医疗保险处方药福利的需求:在管理竞争框架下探索消费者偏好。
Inquiry. 2003 Summer;40(2):169-83. doi: 10.5034/inquiryjrnl_40.2.169.
2
Prescription drug coverage and seniors: how well are states closing the gap?处方药覆盖范围与老年人:各州在缩小差距方面做得如何?
Health Aff (Millwood). 2002 Jul-Dec;Suppl Web Exclusives:W253-68. doi: 10.1377/hlthaff.w2.253.
3
Trends in Medicare supplemental insurance and prescription drug coverage, 1996-1999.1996 - 1999年医疗保险补充保险和处方药覆盖情况的趋势
Health Aff (Millwood). 2002 Jul-Dec;Suppl Web Exclusives:W127-38. doi: 10.1377/hlthaff.w2.127.
4
A Medicare prescription drug benefit: focusing on coverage and cost.一项医疗保险处方药福利:聚焦于覆盖范围和成本。
Issue Brief (Commonw Fund). 2002 Apr(538):1-6.
5
Designing a Medicare drug benefit: whose needs will be met?设计一项医疗保险药品福利计划:谁的需求将得到满足?
Policy Brief Commonw Fund. 2000 Dec(436):1-8.
6
State pharmaceutical assistance programs for older and disabled Americans.针对美国老年人和残疾人的州药品援助计划。
Health Aff (Millwood). 2001 Sep-Oct;20(5):223-32. doi: 10.1377/hlthaff.20.5.223.
7
Medicare and prescription drugs.医疗保险与处方药。
N Engl J Med. 2001 Mar 29;344(13):1010-5. doi: 10.1056/NEJM200103293441311.
8
The case for a medicare drug coverage benefit: a critical review of the empirical evidence.医疗保险药品覆盖福利的情况:对实证证据的批判性回顾。
Annu Rev Public Health. 2001;22:49-61. doi: 10.1146/annurev.publhealth.22.1.49.
9
Growing differences between Medicare beneficiaries with and without drug coverage.有药物保险和没有药物保险的医疗保险受益人之间的差异越来越大。
Health Aff (Millwood). 2001 Mar-Apr;20(2):74-85. doi: 10.1377/hlthaff.20.2.74.
10
Designing a Medicare prescription drug benefit: issues, obstacles, and opportunities.设计医疗保险处方药福利:问题、障碍与机遇。
Health Aff (Millwood). 2000 Mar-Apr;19(2):26-41. doi: 10.1377/hlthaff.19.2.26.

探索对自愿性医疗保险处方药福利的需求。

Exploring the demand for a voluntary Medicare prescription drug benefit.

作者信息

Cline Richard R, Mott David A

机构信息

College of Pharmacy, University of Minnesota, 308 Harvard St SE, Minneapolis, MN 55455, USA.

出版信息

AAPS PharmSci. 2003;5(2):E19. doi: 10.1208/ps050219.

DOI:10.1208/ps050219
PMID:12866945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2751526/
Abstract

The purposes of this study were (1) to assess the utility of the economic theory of demand for insurance for modeling voluntary Medicare drug benefit enrollment decisions and (2) to explore the degree of adverse selection and crowd-out that might occur under a voluntary enrollment Medicare prescription benefit. Data were collected using a cross-sectional, mail survey of 2,100 community-dwelling adults aged 65 and older in Wisconsin. Respondents were asked to evaluate their likelihood of enrollment in any of 4 hypothetical drug benefit plans under the assumption that they could enroll in one of the hypothetical plans or maintain their current coverage. Data analyses included bivariate comparisons across enrollment likelihood categories and logit analysis of enrollment likelihood as a function of respondent characteristics. 1041 usable survey forms were returned for an adjusted response rate of 51.5%. Older adults with 4 or more chronic conditions were most likely to report that they were "very likely" to enroll in one of the hypothetical drug plans, as were those with the highest out-of-pocket drug spending in the previous 30 days. Respondents with no or self-purchased drug benefits were more likely than those with employer-based plans to express a higher likelihood of enrollment in one of the hypothetical plans. Adverse selection may be problematic for a voluntary enrollment Medicare drug benefit. Given that high out-of-pocket drug spending (secondary to drug coverage source) was a consistent predictor of enrollment likelihood, demand-side factors affecting the crowding out of employer-based drug coverage sources by a voluntary enrollment drug benefit appear minimal. However, the availability of a Medicare prescription benefit may still lead to crowd-out through employer incentives.

摘要

本研究的目的是

(1)评估保险需求的经济理论在模拟自愿参加医疗保险药品福利计划决策方面的效用;(2)探究在自愿参保的医疗保险处方药福利计划下可能出现的逆向选择和挤出效应的程度。通过对威斯康星州2100名65岁及以上居住在社区的成年人进行横断面邮件调查来收集数据。受访者被要求在假设他们可以参加4种假设的药品福利计划之一或维持现有保险范围的情况下,评估他们参加其中任何一种计划的可能性。数据分析包括对不同参保可能性类别的双变量比较,以及将参保可能性作为受访者特征的函数进行逻辑分析。共收回1041份可用调查问卷,调整后的回复率为51.5%。患有4种或更多慢性病的老年人最有可能表示他们“非常有可能”参加其中一种假设的药品计划,前30天自付药品费用最高的人也是如此。没有药品福利或自行购买药品福利的受访者比有雇主提供药品福利计划的受访者更有可能表示参加其中一种假设计划的可能性更高。对于自愿参保的医疗保险药品福利计划来说,逆向选择可能是个问题。鉴于高额的自付药品费用(因药品保险来源而异)一直是参保可能性的预测指标,可以看出,影响自愿参保药品福利计划挤出雇主提供药品保险来源的需求方因素似乎微乎其微。然而,医疗保险处方药福利的可获得性仍可能通过雇主激励措施导致挤出效应。